ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 544

Ultraviolet-B Induced Plasmacytoid Dendritic Cell Migration and Type 1 Interferon Signaling In The Skin

Clayton Sontheimer1, Thomas H. Teal2, Nalini Agrawal2, Denny Liggitt3 and Keith B. Elkon4, 1Pediatric Rheumatology, University of Washington, Seattle, WA, 2Rheumatology, University of Washington, Seattle, WA, 3Comparative Medicine, University of Washington, Seattle, WA, 4Department of Medicine & Immunology, University of Washington, Seattle, WA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Interferons and skin

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Plasmacytoid dendritic cells (pDCs) are highly specialized cells of the innate immune system that secrete very high levels of interferon alpha (IFN-a) following nucleic acid ligand mediated activation of the Toll-like receptors (TLRs) 7 and 9. Although the presence of large numbers of pDC in the skin of patients with cutaneous lupus and exacerbation of cutaneous lupus by UVB exposure suggests a causal relationship, a direct link is difficult to prove. In mice, pDC have been observed in the skin following virus infections as well as following injury by tape stripping but studies of UVB are very limited.  Here, we asked whether, and under what conditions, UVB-induced inflammation could recruit pDC and type 1 IFN to the skin. 

Methods: Shaved C57BL/6 (B6) mice were irradiated with UVB with either a single dose of 500 mJ/cm2 (acute profile) or with 100 mJ/cm2/day for 5 consecutive days (subacute profile). Serial punch biopsies (6 mm) were obtained at 3, 24, and 72 hrs following UVB exposure.  Skin samples were examined for mRNA expression by quantitative PCR of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and Type 1 stimulated genes (MX1, ISG15, ISG20).  mRNA fold change was calculated against non-irradiated control mice.  Skin samples were also evaluated by histology with H&E staining and for the presence of pDCs by staining for the pDC-specific marker Siglec H by immunohistochemistry. The skin was also scored visually in a blinded manner based on degree of erythema and ulceration.

Results: While producing similar levels of IL-1β, TNF-α and IL-6, subacute UVB exposure of B6 mice preferentially induced expression of Type 1 IFN genes when compared to both acute UVB and non-irradiated controls.  IFN-response genes were elevated at each time point with the greatest increase occurring at 72 hours post-UVB.  Subacute UVB exposure also induced transient pDCs infiltration into the dermis and hypodermis that corresponded with Type 1 IFN response genes. To examine the role of UVB-induced Type 1 IFN, subacute UVB-mediated effects in B6 mice were compared to age matched IFNAR KO mice (also on a B6 background).  IFNAR KO mice had increased levels of the pro-inflammatory cytokines, IL-1β and IL-6 at 3 and 24 hrs following UVB compared to B6 mice.  Interestingly, TNF-α levels were similar between B6 and IFNAR KO mice.  Skin scoring for erythema and ulceration showed increased levels of skin damage at 3 and 24 hrs.

Conclusion: Repeated moderate dose of UVB preferentially induced pDC recruitment and Type 1 interferon signature in the skin.  Based on the findings that skin damage and inflammatory cytokines were higher in IFNAR KO compared to control mice following subacute UVB exposure, we conclude that Type 1 IFN plays a protective role in attenuating the acute inflammatory response following repeated UVB exposure. It is likely that repetitive UVB exposure as well as other genetic factors leading to hyperresponsiveness to nucleic acid debris, predispose to lupus.


Disclosure:

C. Sontheimer,
None;

T. H. Teal,
None;

N. Agrawal,
None;

D. Liggitt,
None;

K. B. Elkon,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultraviolet-b-induced-plasmacytoid-dendritic-cell-migration-and-type-1-interferon-signaling-in-the-skin/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology